From the reviews:

“This book … can be viewed as an update on all one wants to know about age-related macular degeneration (AMD), what is new and what keeps AMD researchers’ and clinicians’ minds ‘racing’; whether it is genetics, modifiable risk factors, therapy and management, as well as future directions in treatment and its limitations. … this book will definitely have its place in clinical ophthalmic practice and it will be a very useful source for academic reference and teaching purposes.” (Beatrix Feigl, Clinical and Experimental Optometry, Vol. 95, July, 2012)